Initial reporter occupation: non-healthcare professional.Investigation: it has not been possible to further investigate or evaluate this alleged event based on the limited information and/or no device failure provided to date.Catalog number and lot number are unknown, however, the alleged tulip is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.
|
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.H10: please see mdr number 1820334-2020-01957 for the event detailing the vena cava filter placed inferiorly.Investigation: the following allegations have been investigated: hematoma with hospitalization, worry, fear, anxiety, physical limitations.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.Unknown if the reported hematoma with hospitalization, worry, fear, anxiety, and physical limitations are directly related to the filter and unable to identify a corresponding failure mode at this point in time.A total of 10 devices were manufactured in the reported lot.To date, no other complaints have been reported against the lot.The associated work order was reviewed.No related/relevant notes were documented.The device is manufactured and inspected according to current controls this report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|
Patient allegedly received this implant on (b)(6) 2006 via the right common femoral vein due to left humeral fracture, documented superficial venous thrombosis, and contraindication for anticoagulation therapy.A previous gunther-tulip filter had been placed (b)(6) 2006 in an infrarenal position.This file concerns the filter placed (b)(6) 2006 in the superior vena cava.Patient is alleging developed hematoma at filter site.Patient notes and further alleges experiencing "i suffered a right lower extremity hematoma post ivc filter placement which required inpatient hospital treatment"."i cannot do the things i used to due to and worrying about future complications with the filter.I have to take every thing i do very slowly.I suffer from severe fear and anxiety of future harm or death" as well as physical limitations.
|